RCM Tech Q3 2023 revenue $58M, net income $3.8M ($0.46 EPS); nine-month results decline

RCM TECHNOLOGIES, INC.

2023-Q3 EPS reported $1.33 revenue$192,209,000

Q3 revenue $58.0M (-0.2% YoY); gross profit $17.3M (-0.4% YoY).
GAAP net income $3.8M ($0.46 diluted EPS) vs $3.5M ($0.33) prior year.
Adjusted EBITDA (non-GAAP) $4.6M vs $4.8M in prior-year quarter.
Nine-month revenue $192.2M (-10.4% YoY); net income $11.6M ($1.33 diluted EPS).
Q3 gross margin improved 180 bps over Q2; management expects Q4 to be strongest quarter.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

RCM TECHNOLOGIES, INC. reported the thirteen and thirty-nine weeks ended September 30, 2023 results: revenue $192.2 million, net income $11.6 million, or $1.33 per diluted share, EPS $1.33 per diluted share.

Period: the thirteen and thirty-nine weeks ended September 30, 2023
Revenue: $192.2 million
Net income: $11.6 million, or $1.33 per diluted share
EPS: $1.33 per diluted share
Result: reported results

Exact text from the filing

RCM Technologies reported revenue of $58.0 million for the thirteen weeks ended September 30, 2023 (the current period)

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Period: the thirteen and thirty-nine weeks ended September 30, 2023
Revenue: $192.2 million
Net income: $11.6 million, or $1.33 per diluted share
EPS: $1.33 per diluted share
Result: reported results

Exact text from the filing

RCM Technologies reported revenue of $192.2 million for the thirty-nine weeks ended September 30, 2023 (the current period)

View on SEC.gov

Browse all earnings releases →

RCM TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-030962

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.